Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

15

Revenue 2017

Neulasta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Neulasta was produced by Amgen.

Sandoz finally wins FDA approval for Neulasta biosimilar

Sandoz finally wins FDA approval for Neulasta biosimilar

Amgen had a lucky break when the FDA initially rejected Sandoz’ Neulasta biosimilar back in 2016, as the US market accounts for the bulk of its sales for this medicine. ... Neulasta had been one of Amgen’s biggest commercial products, but has been 

Amgen exits neuroscience R&D to focus on growth areas

Amgen exits neuroscience R&D to focus on growth areas Away from its neuroscience news, Amgen reported a 3% decline in revenues to $5.74bn on its third-quarter update, with red blood cell stimulators Neupogen and Neulasta both plummeting around

Amgen buys Danish partner Nuevolution for $167m

Amgen buys Danish partner Nuevolution for $167m The company is starting to face biosimilar competition for white blood cell stimulator Neulasta (pegfilgrastim) as well as generic encroachment on Sensipar (cinacalcet) for secondary hyperparathyroidism, which together accounted for around

Amgen CEO says Aimovig is “one of most successful launches”

Amgen CEO says Aimovig is “one of most successful launches” Overall, Amgen posted a 2% rise in revenues to $5.78bn in the quarter, despite pressure on older drugs like while blood cell booster Neulasta (pegfilgrastim) which showed the first signs

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals and ERA Consulting’s Udenyca (pegfilgrastim), both alternatives to Amgen’s Neulasta  brand for neutropenia and febrile neutropenia due to chemotherapy.

1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of animators and science experts creating photo real life-science animation content for the healthcare and...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics